A loss of Iba1 and other microglial markers has been recently described in neurodegenerative disorders such as Alzheimer’s and Huntington diseases, correlating in some cases with disease severity [39, 76, 77]. This evidence concerns the gene AIF1 and juvenile Huntington disease.